Lung Innate Immunity Research Laboratory, Program in Physiology and Experimental Medicine, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada.
J Biol Chem. 2010 Apr 30;285(18):13461-70. doi: 10.1074/jbc.M110.108837. Epub 2010 Mar 5.
Surfactant protein D (SP-D) is an innate immune collectin that recognizes microbes via its carbohydrate recognition domains, agglutinates bacteria, and forms immune complexes. During microbial infections, proteases, such as elastases, cleave the carbohydrate recognition domains and can inactivate the innate immune functions of SP-D. Host responses to counterbalance the reduction of SP-D-mediated innate immune response under these conditions are not clearly understood. We have unexpectedly identified that SP-D could interact with protein fractions containing ovomucin and ovomacroglobulin. Here, we show that SP-D interacts with human alpha(2)-macroglobulin (A2M), a protease inhibitor present in the lungs and serum. Using enzyme-linked immunosorbent assays, surface plasmon resonance, and carbohydrate competition assays, we show that SP-D interacts with A2M both in solid phase (K(D) of 7.33 nM) and in solution via lectin-carbohydrate interactions under physiological calcium conditions. Bacterial agglutination assays further show that SP-D x A2M complexes increase the ability of SP-D to agglutinate bacteria. Western blot analyses show that SP-D, but not A2M, avidly binds bacteria. Interestingly, intact and activated A2M also protect SP-D against elastase-mediated degradation, and the cleaved A2M still interacts with SP-D and is able to enhance its agglutination abilities. We also found that SP-D and A2M can interact with each other in the airway-lining fluid. Therefore, we propose that SP-D utilizes a novel mechanism in which the collectin interacts with protease inhibitor A2M to decrease its degradation and to concurrently increase its innate immune function. These interactions particularly enhance bacterial agglutination and immune complex formation.
表面活性蛋白 D(SP-D)是一种先天免疫凝聚素,通过其碳水化合物识别结构域识别微生物,聚集细菌,并形成免疫复合物。在微生物感染过程中,弹性蛋白酶等蛋白酶会切割碳水化合物识别结构域,从而使 SP-D 的先天免疫功能失活。宿主对这些情况下 SP-D 介导的先天免疫反应减少的反应机制尚不清楚。我们意外地发现 SP-D 可以与含有卵黏蛋白和卵巨球蛋白的蛋白质片段相互作用。在这里,我们表明 SP-D 与人类α2-巨球蛋白(A2M)相互作用,A2M 是一种存在于肺部和血清中的蛋白酶抑制剂。我们通过酶联免疫吸附测定、表面等离子体共振和碳水化合物竞争测定,显示在生理钙条件下,SP-D 通过凝集素-碳水化合物相互作用在固相(K(D)为 7.33 nM)和溶液中与 A2M 相互作用。细菌聚集测定进一步表明,SP-D x A2M 复合物增加了 SP-D 聚集细菌的能力。Western blot 分析表明,SP-D 而不是 A2M 能够强烈结合细菌。有趣的是,完整和激活的 A2M 还可以保护 SP-D 免受弹性酶介导的降解,并且切割的 A2M 仍然与 SP-D 相互作用并能够增强其聚集能力。我们还发现 SP-D 和 A2M 可以在气道衬里液中相互作用。因此,我们提出 SP-D 利用一种新的机制,即凝聚素与蛋白酶抑制剂 A2M 相互作用,以降低其降解并同时增强其先天免疫功能。这些相互作用特别增强了细菌的聚集和免疫复合物的形成。